Literature DB >> 33135560

Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Jacob Szpernal1, Joseph Carroll2,3,4, Ryan Spellecy5, Jane A Bachman Groth2.   

Abstract

Standards in pupil dilation practices regarding the safety of human subjects are not present in vision research despite the potential for significant adverse effects. We developed two surveys to examine current practices around pupil dilation among vision researchers and individuals associated with oversight of human subjects research. While both groups note an absence of adverse events associated with pupil dilation, vision researcher practices differed with informed consent use and measures taken to minimize complications. For Institutional Review Boards, general risk assumption associated with dilation was not unanimous and there was a lack of specific guidance available to researchers for minimizing risk. These results uncover the need for standardized practices regarding pupil dilation in human subjects research.

Entities:  

Keywords:  consent; ophthalmology; optometry; pupil dilation; risk; safety

Year:  2020        PMID: 33135560      PMCID: PMC8035129          DOI: 10.1177/1556264620968989

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  37 in total

1.  Phenylephrine is a frequent cause of periorbital allergic contact dermatitis.

Authors:  Jakob T Madsen; Klaus E Andersen
Journal:  Contact Dermatitis       Date:  2015-04-09       Impact factor: 6.600

2.  Administering eyedrops.

Authors:  Jill Rushing
Journal:  Nursing       Date:  2007-05

3.  Neurotoxic Effects of Topical Cyclopentolate.

Authors:  A Rajeev; G Gupta; K M Adhikari; A K Yadav; M Sathyamoorthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.

Authors:  Bethany Stavert; Myra B McGuinness; C Alex Harper; Robyn H Guymer; Robert P Finger
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

5.  Use of diagnostic pharmaceutical agents and incidence of adverse effects.

Authors:  M Applebaum; S D Jaanus
Journal:  Am J Optom Physiol Opt       Date:  1983-05

6.  The national registry of drug-induced ocular side effects.

Authors:  F T Fraunfelder; S M Meyer
Journal:  Aust J Ophthalmol       Date:  1984-05

7.  3. Phenylephrine hydrochloride.

Authors:  S M Meyer; F T Fraunfelder
Journal:  Ophthalmology       Date:  1980-11       Impact factor: 12.079

8.  Systemic absorption and anticholinergic activity of topically applied tropicamide.

Authors:  M L Vuori; T Kaila; E Iisalo; K M Saari
Journal:  J Ocul Pharmacol       Date:  1994

9.  Cataract surgery in patients with acute primary angle-closure glaucoma.

Authors:  Jae Yoon Yoon; Young Jae Hong; Chan Yun Kim
Journal:  Korean J Ophthalmol       Date:  2003-12

10.  Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.

Authors:  Akemi Wakayama; Sachiko Nishina; Atsushi Miki; Takashi Utsumi; Jun Sugasawa; Takao Hayashi; Miho Sato; Akiko Kimura; Takashi Fujikado
Journal:  Jpn J Ophthalmol       Date:  2018-07-25       Impact factor: 2.447

View more
  1 in total

1.  Pupillary Dilation in Research: More than Meets the Eye.

Authors:  Jacob Szpernal; Jane A Bachman Groth; Niamh Wynne; Vesper Williams; Ryan Spellecy; Catherine Thuruthumaly; Joseph Carroll
Journal:  Curr Eye Res       Date:  2022-05-02       Impact factor: 2.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.